PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

U.S. public may not be aware of important uncertainties about drug benefits and harms

Explaining these uncertainties might improve their choices

2011-09-13
(Press-News.org) CHICAGO – Many U.S. adults believe that only extremely effective drugs without serious adverse effects are approved, but providing explanations to patients highlighting uncertainties about drug benefits may affect their choices, according to a report in the September issue of Archives of Internal Medicine, one of the JAMA/Archives journals. The article is part of the journal's Less Is More series.

Approval from the U.S. Food and Drug Administration (FDA) does not necessarily ensure that a drug has a large or important benefit, or that all serious adverse effects of the drug are known, according to background information in the article. "Uncertainties are greatest in the first few years after approval and for drugs approved solely on the basis of a surrogate outcome," the authors note. They point out that the cholesterol-lowering drugs Zetia and Vytorin reached $1.8 billion in sales in 2007 before a study found no clinical benefit from these drugs, and that the anti-inflammatory medication Vioxx reached $2.4 billion in sales by 2003 before being withdrawn from the market due to its association with myocardial infarctions (heart attacks) and strokes. "The FDA has never required advertisements to acknowledge uncertainties inherent in all new drugs," write the authors. "Enthusiasm for Zetia and Vioxx … might have been dampened had consumers known to look for drugs approved based on patient outcomes or drugs with a longer safety record."

Lisa Schwartz, M.D., M.S., and Steven Woloshin, M.D., M.S., from the VA Outcomes Group, White River Junction VA Medical Center, White River Junction, Vt., and the Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, N.H., conducted an Internet-based, randomized, controlled trial of U.S. adults' beliefs and choices regarding prescription drug uncertainties. The 2,944 participants were randomized to three explanations about a pair of cholesterol drugs, one that was approved because of a surrogate outcome (lower cholesterol) and another that was approved because of a patient outcome (reduced myocardial infarctions). Participants in the control group received no explanation, those in the nondirective group were told that surrogate outcomes do not always translate into patient outcomes and those in the directive group received the same explanation as well as advice to "Ask for a drug shown to reduce heart attacks."

In a second randomization, participants received one of three explanations about a pair of heartburn drugs, one that was newly approved and another that was approved eight years earlier. Participants in the control group received no explanation, those in the nondirective group were told "It takes time to establish the safety of new drugs" and those in the directive group were advised to "Ask for a drug with a longer track record."

The primary outcome was choice of the drug for which there was less uncertainty. In the cholesterol drug example, the better choice would be the drug that had a beneficial effect on patient outcome (reducing myocardial infarction) instead of surrogate outcome (lowering cholesterol). In the heartburn drug example, the better choice would be the drug that was approved eight years earlier instead of the recently approved drug. Researchers also asked participants, "What would you do if your doctor recommended the drug with the surrogate outcome? Do you think new—or old—drugs are safer?" and assessed their understanding of FDA approval with four true/false questions.

One-quarter of participants mistakenly believed that the FDA approves only drugs without serious side effects, and more than one-third mistakenly believed that the FDA approves only "extremely effective" drugs. Equal percentages of participants in the directive and nondirective groups (71 percent in the cholesterol drug example and 53 percent in the heartburn drug example) chose the drug for which there was less uncertainty. In both examples, choice of the drug for which there was less uncertainty was lowest among the control group (59 percent and 34 percent, respectively). When asked what they would do if their physician recommended the drug approved for a surrogate outcome, 61 percent, 58 percent and 49 percent of participants in the directive, nondirective and control groups, respectively, said they would request the drug approved for a patient outcome. When asked which of the heartburn drugs was safer, 46 percent, 45 percent and 31 percent of the directive, nondirective and control groups, respectively, selected the older drug. The proportion of participants who chose the older heartburn drug and said it was safer was 40 percent, 41 percent and 26 percent, respectively. One limitation the authors note is "participants were making hypothetical choices between drugs."

"There are important gaps in what people know about prescription drugs—gaps that undoubtedly contribute to the rapid uptake of drugs despite uncertainty about benefit and harm," write the authors. "Our findings show that simple explanations (ones that are brief enough even for television advertisements) help consumers make better decisions." They recommend that the FDA more effectively communicate what it knows and does not know about how well drugs work.

(Arch Intern Med. 2011;171[16]:1463-1468. Available pre-embargo to the media at www.jamamedia.org.)

Editor's Note: This study was supported by a grant from the Attorney General Consumer and Prescriber Education grant program and Robert Wood Johnson's Pioneer Program. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Commentary: Using Patients to Promote Evidence-Based Prescribing

In an accompanying commentary, Michael A. Steinman, M.D., from the San Francisco VA Medical Center, considers the implications of the study by Schwartz and Woloshin, which he calls "a patient-oriented approach to promote use of drugs with proven clinical benefit and a well-established track record of safety." Although study participants who received the explanations about the drugs were more likely to choose the drug for which there was less uncertainty, Steinman points out that some individuals in these groups chose the drugs that had no evidence of clinical benefit or a longer track record of safety.

"Simply adding warnings to patient educational materials is unlikely to meaningfully increase rational prescribing," he writes. "Nonetheless, giving patients warnings and instructions may be of substantial value if we also provide them the tools to help them successfully advocate for their own care." Steinman describes efforts to encourage patients to speak with their physicians about medication choices and to advocate for themselves. "Patient activation programs are a valuable tool to provide better care," he concludes. "We should take full advantage."

### (Arch Intern Med. 2011;171[16]:1468-1469. Available pre-embargo to the media at www.jamamedia.org.)

Editor's Note: Dr. Steinman's work was supported by the National Institute on Aging and the American Federation for Aging Research. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

To contact Steven Woloshin, M.D., M.S., call Deborah G. Kimbell at 603-650-6694 or e-mail deborah.kimbell@dartmouth.edu. To contact commentary author Michael A. Steinman, M.D., call Judi Cheary at 415-750-3350 or e-mail judi.cheary2@va.gov. END


ELSE PRESS RELEASES FROM THIS DATE:

Association found between long-term use of nonaspirin anti-inflammatory drugs and renal cell cancer

2011-09-13
CHICAGO – Long-term use of nonaspirin anti-inflammatory drugs (NSAIDs) is associated with an increased risk of renal cell cancer (RCC), according to a report in the September issue of Archives of Internal Medicine, one of the JAMA/Archives journals. According to background information in the article, in the United States, kidney cancer is the seventh leading type of cancer among men and the ninth leading type of cancer among women. The most common type of kidney cancer, renal cell cancer, accounts for 85 percent of all cases. Analgesics (pain-relieving medications) are ...

Cardiovascular implantable electronic device-related infections linked with increased risk of death

2011-09-13
CHICAGO – An association has been found between infection associated with cardiovascular implantable electronic devices (CIEDs) and increases in mortality and hospital care costs, according to a report published Online First by Archives of Internal Medicine, one of the JAMA/Archives journals. The article is part of the journal's Health Care Reform series. Therapy with CIEDs, which include pacemakers, implantable cardioverter-defibrillators and cardiac resynchronization therapy/defibrillator devices, can reduce illness and death rates in appropriately selected patients, ...

Skin Solutions Medical Spa in Arvada Announces Their New Express Rejuvenation Day, Express Facials For Busy Professionals

Skin Solutions Medical Spa in Arvada Announces Their New Express Rejuvenation Day, Express Facials For Busy Professionals
2011-09-13
Skin Solutions Medical Spa has been serving the Denver Metro area for the past 15 years and was recently nominated for Denver 7's A-List as Denver's best Medical Spa. The spa stands out in the community by providing the highest level of customer service while producing state-of-the-art cosmetic procedures and aesthetic treatments that are safe and effective. The announcement of Express Rejuvenation Day shows the spa's commitment to provide even more quality to their clients and community. Skin Solutions Medical Spa's new Express Rejuvenation Day was driven by the demand ...

New harmonized cardiovascular treatment guidelines make heart disease treatment easier

2011-09-13
A new set of harmonized guidelines for the management of risk factors for cardiovascular disease will make it much easier for physicians to care for their patients, according to the authors of the C-CHANGE guidelines published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/site/embargo/cmaj101508.pdf. The Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) Initiative harmonized and integrated more than 400 separate recommendations from 8 sets of guidelines into one comprehensive but simplified resource. ...

Fast-paced, fantastical television shows may compromise learning, behavior of young children

2011-09-13
Young children who watch fast-paced, fantastical television shows may become handicapped in their readiness for learning, according to a new University of Virginia study published in the October issue of the journal Pediatrics. U.Va. psychologists tested 4-year-old children immediately after they had watched nine minutes of the popular show "SpongeBob SquarePants" and found that their executive function – the ability to pay attention, solve problems and moderate behavior – had been severely compromised when compared to 4-year-olds who had either watched nine minutes of ...

Costs, mortality skyrocket following infection in cardiac device recipients

2011-09-13
Monmouth Junction, NJ (September 12, 2011): A new study finds that infections following cardiac device implantations or replacement result in extremely high costs, both financially and in terms of patient mortality, even months after affected patients return home. Infections associated with pacemakers and defibrillators led to 4.8 to 7.7-fold increases in admission mortality, 1.6 to 2.1-fold increases long term mortality, 2.5 to 4.0-fold increases in hospital length of stay, and 1.4 to 1.8-fold increases in cost compared to pacemaker and defibrillator implantations without ...

High medical costs decrease 28 percent after 5 years of Transcendental Meditation practice

High medical costs decrease 28 percent after 5 years of Transcendental Meditation practice
2011-09-13
According to a study published this week in the September/October 2011 issue of the American Journal of Health Promotion (Vol. 26, No. 1, pp. 56-60), people with consistently high health care costs experienced a 28 percent cumulative decrease in physician fees after an average of five years practicing the stress-reducing Transcendental Meditation technique compared with their baseline. Both between and within group comparisons were statistically significant. This study has major policy implications. In most populations, a small fraction of people account for the majority ...

MIT: In plane view

2011-09-13
CAMBRIDGE, Mass. -- An airplane's digital flight-data recorder, or "black box," holds massive amounts of data, documenting the performance of engines, cockpit controls, hydraulic equipment and GPS systems, typically at regular one-second intervals throughout a flight. Inspectors use such data to reconstruct the final moments of an accident, looking for telltale defects that may explain a crash. More recently, analysts have probed black-box data in an effort to prevent such accidents from ever occurring. Using software tools that can rapidly search data, operators can ...

Social contacts, self-confidence crucial to successful recovery through Alcoholics Anonymous

2011-09-13
Among the many ways that participation in Alcoholics Anonymous (AA) helps its members stay sober, two appear to be most important – spending more time with individuals who support efforts towards sobriety and increased confidence in the ability to maintain abstinence in social situations. In a paper that will appear in the journal Addiction and has been released online, researchers report the first study to examine the relative importance to successful recovery of the behavior changes associated with participation in AA. "AA is the most commonly sought source of help ...

Treatment of CV risk factors appears to improve sexual function in men with erectile dysfunction

2011-09-13
CHICAGO – Lifestyle modifications and pharmaceutical treatment of risk factors for cardiovascular disease are associated with improvement in sexual function among men with erectile dysfunction (ED), according to a meta-analysis posted Online First today in Archives of Internal Medicine, one of the JAMA/Archives journals. "Erectile dysfunction shares modifiable risks factors with atherosclerosis and coronary artery disease (CAD), including hypertension, diabetes, dyslipidemia, cigarette smoking, obesity, metabolic syndrome, and sedentary behavior," according to background ...

LAST 30 PRESS RELEASES:

Being physically active, even just a couple of days a week, may be key to better health

High-fat diet promote breast cancer metastasis in animal models

A router for photons

Nurses and AI collaborate to save lives, reduce hospital stays

Multi-resistance in bacteria predicted by AI model

Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection

Sensing sickness

Cost to build multifamily housing in California more than twice as high as in Texas

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

[Press-News.org] U.S. public may not be aware of important uncertainties about drug benefits and harms
Explaining these uncertainties might improve their choices